Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115599) titled 'Research on the Comprehensive Chain Construction and Application of a Standardized System for HBV Marker Detection' on Dec. 29, 2025.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Beijing Hospital
Condition:
Hepatitis B virus infection
Intervention:
HBcAb Group:N/A
HBsAb Group:HBsAb positive
HBsAg Group:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: HBcAb Group:500;HBsAb Group:500;HBsAg Group:500;HBV DNA Group:500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html...